Behcet Basics for Primary Care: Diagnosis
Primary care physicians are in a key position to suspect and detect BD in their patients and refer them to a rheumatologist to confirm the diagnosis and initiate a treatment plan.
Behçet disease (BD) is rare in the United States (5.2 per 100,000 population) but may result in significant morbidity and mortality, says the American Behçet's Disease Association (ABDA). Because there is no specific diagnostic test for this multisystem inflammatory disorder and diagnosis is based on clinical criteria, the correct diagnosis often is not made until more than 5 years from the onset of symptoms.
Patient care and treatment often require a multidisciplinary team, and rheumatologists are the main physicians involved. But primary care physicians are in a key position to suspect and detect BD in their patients and refer them to a rheumatologist to confirm the diagnosis and initiate a treatment plan.
FDA Approves Esketamine as Monotherapy for Adults With Treatment-Resistant Depression
January 21st 2025The approval of esketamine follows an FDA Priority Review and is based on data showing that esketamine alone demonstrated rapid and superior improvement in depressive symptoms compared with placebo.
